Course: Gestational Diabetes and Long-Term Cardiometabolic Health
CME Credits: 1.00
Released: 2023-08-10
Gestational diabetes mellitus (GDM) (ie, hyperglycemia first diagnosed during pregnancy) is associated with increased risk of adverse perinatal outcomes. GDM is associated with cardiometabolic disease including type 2 diabetes (T2D) and cardiovascular disease (CVD) in the affected pregnant individual and the exposed fetus. In 2020, GDM occurred in nearly 1 in 8 pregnancies in the US, with even higher rates among individuals who identified as American Indian or non-Hispanic Asian/Pacific Islander, those with obesity, and those aged 35 years or older at delivery. The age-standardized rate of GDM at the first live birth has increased from 47.6 to 63.5 per 1000 live births from 2011 to 2019 in the US, with further increases documented during the COVID-19 pandemic.
To identify the key insights or developments described in this article
View Full Course